Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cansortium (CNTMF)
OTHER OTC:CNTMF
Cansortium (CNTMF) Stock Price & Analysis
66 Followers
CNTMF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.06 - $0.29
Previous Close$0.2
Volume2.00K
Average Volume (3M)402.06K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$12.11M
Total Debt (Recent Filing)$97.78M
Price to Earnings (P/E)-2.2
Beta1.52
Next Earnings
Apr 30, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding298,345,160
10 Day Avg. Volume390,341
30 Day Avg. Volume402,061
Standard Deviation0.30
R-Squared0.26
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)-0.50
Price to Sales (P/S)0.62
Price to Cash Flow (P/CF)1.40
P/FCF Ratio2.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Cansortium News
PremiumPress Releases
Cansortium Reports Third Quarter 2023 Results
PremiumPress Releases
Cansortium Announces Shares for Debt Settlement
Options Prices
Currently, No data available
---
Ownership Overview
24.58% Insiders
0.09% Mutual Funds
0.40% Other Institutional Investors
74.92% Public Companies and
Individual Investors
CNTMF FAQ
What was Cansortium’s price range in the past 12 months?
Cansortium lowest stock price was $0.06 and its highest was $0.29 in the past 12 months.
What is Cansortium’s market cap?
Currently, no data Available
When is Cansortium’s upcoming earnings report date?
Cansortium’s upcoming earnings report date is Apr 30, 2024 which is in 10 days.
How were Cansortium’s earnings last quarter?
Cansortium released its earnings results on Nov 29, 2023. The company reported -$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.01.
Is Cansortium overvalued?
According to Wall Street analysts Cansortium’s price is currently Overvalued.
Does Cansortium pay dividends?
Cansortium does not currently pay dividends.
What is Cansortium’s EPS estimate?
Cansortium’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cansortium have?
Cansortium has 272,418,520 shares outstanding.
What happened to Cansortium’s price movement after its last earnings report?
Cansortium reported an EPS of -$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Cansortium?
Currently, no hedge funds are holding shares in CNTMF
---
Cansortium Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Company Description
Cansortium
Cansortium, Inc. engages in the production and sale of medical cannabis. It focuses on oil extracted and derived products for use by medical patients. Its objective is to invest in and develop multiple jurisdictions for the vertical integrated approach for the sale, and distribution of processed cannabis oil in medical use frameworks. The company was founded on August 31, 2018 and is headquartered in Miami, FL.
---
CNTMF Earnings Call
Q3 2023
0:00 / 0:00
---
Technical Analysis
---